Indaptus Current Ratio from 2010 to 2024
INDP Stock  USD 1.27 0.14 12.39% 
Current Ratio  First Reported 20101231  Previous Quarter 5.04507843  Current Value 9.25  Quarterly Volatility 9.78853772 
Check Indaptus Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Indaptus Therapeutics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.2 K, Interest Expense of 710.1 K or Selling General Administrative of 5.3 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 1.29. Indaptus financial statements analysis is a perfect complement when working with Indaptus Therapeutics Valuation or Volatility modules.
Indaptus  Current Ratio 
Latest Indaptus Therapeutics' Current Ratio Growth Pattern
Below is the plot of the Current Ratio of Indaptus Therapeutics over the last few years. It is a liquidity ratio that measures a company's ability to pay shortterm obligations or those due within one year. It compares a firm's current assets to its current liabilities. Indaptus Therapeutics' Current Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Indaptus Therapeutics' overall financial position and show how it may be relating to other accounts over time.
View  Last Reported 9.18 X  10 Years Trend 

Current Ratio 
Timeline 
Indaptus Current Ratio Regression Statistics
Arithmetic Mean  14.06  
Geometric Mean  9.77  
Coefficient Of Variation  69.60  
Mean Deviation  8.91  
Median  9.80  
Standard Deviation  9.79  
Sample Variance  95.82  
Range  24.3377  
RValue  (0.83)  
Mean Square Error  31.80  
RSquared  0.69  
Significance  0.0001  
Slope  (1.82)  
Total Sum of Squares  1,341 
Indaptus Current Ratio History
About Indaptus Therapeutics Financial Statements
Indaptus Therapeutics shareholders use historical fundamental indicators, such as Current Ratio, to determine how well the company is positioned to perform in the future. Although Indaptus Therapeutics investors may analyze each financial statement separately, they are all interrelated. The changes in Indaptus Therapeutics' assets and liabilities, for example, are also reflected in the revenues and expenses on on Indaptus Therapeutics' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last Reported  Projected for Next Year  
Current Ratio  5.05  9.25 
Pair Trading with Indaptus Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Indaptus Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Indaptus Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving together with Indaptus Stock
Moving against Indaptus Stock
0.83  VCYT  Veracyte  PairCorr 
0.81  DMAC  DiaMedica Therapeutics  PairCorr 
0.77  A  Agilent Technologies Fiscal Year End 18th of November 2024  PairCorr 
0.75  VERA  Vera Therapeutics  PairCorr 
0.69  DNLI  Denali Therapeutics  PairCorr 
The ability to find closely correlated positions to Indaptus Therapeutics could be a great tool in your taxloss harvesting strategies, allowing investors a quick way to find a similarenough asset to replace Indaptus Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Indaptus Therapeutics  that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Indaptus Therapeutics to buy it.
The correlation of Indaptus Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between 1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Indaptus Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Indaptus Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Indaptus Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better riskadjusted return on your portfolios.Additional Tools for Indaptus Stock Analysis
When running Indaptus Therapeutics' price analysis, check to measure Indaptus Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Indaptus Therapeutics is operating at the current time. Most of Indaptus Therapeutics' value examination focuses on studying past and present price action to predict the probability of Indaptus Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Indaptus Therapeutics' price. Additionally, you may evaluate how the addition of Indaptus Therapeutics to your portfolios can decrease your overall portfolio volatility.